RANDOMIZED CONTROLLED-TRIAL; INTRAPERITONEAL CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; CURATIVE SURGERY; COMPETING RISK; PHASE-II; S-1; CHEMORADIOTHERAPY; CARCINOMATOSIS; CELLS
JOURNAL OF SURGICAL ONCOLOGY, v.114, no.7, pp.859 - 864
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.